This newly defined fully functional CD4+CD127lowFOXP3+ Treg-cell population is expanded in all tumor entities as well as the premalignant MGUS supporting the hypothesis of increased Treg cells as a rather early event during tumor development. The gene discussed is CD4; the disease is neoplasm.